PAR-25-083-Full-Announcement.html

This document is a Funding Opportunity Announcement (FOA) for the federal grant opportunity titled "Co-infection and Cancer (R21 Clinical Trial Not Allowed)". The purpose of this FOA is to enhance research on the roles of co-infection and cancer, with the goal of informing prevention and treatment strategies for infection-related cancers. Eligible applicant types include independent school districts, non-profit organizations, small businesses, and higher education institutions, among others. The funding will be provided in the form of grants under the "Cancer Control" federal grant program (CFDA 93.399), which is administered by the Department of Health and Human Services' National Institutes of Health. The FOA does not specify award amounts or deadlines, but indicates a preference for investigations of co-infections with known oncogenic agents (excluding HIV) and novel opportunities for prevention and treatment.